Clinical Trials Browser

OTHER × gallium maltolate × 90 days × Clear all

NCT07515924 2026-04-07

Oral Gallium Maltolate for Recurrent Glioblastoma

Phase EARLY_PHASE1 Not yet recruiting

Glioblastoma